Related Image: Great apes endangered by human viruses |
(Date:5/18/2012)... Hospitals (UH) Case Medical Center and CardioKinetix Inc., ... for heart failure, today announced promising results for ... Percutaneous Ventricular Restoration Therapy (PVRT) technology for patients ... two-year clinical results were presented today (May 18, ... Late Breaking Science Hot Line session at the ...
(Date:5/17/2012)... participate in genetic testing that can indicate their ... these results does not appreciably drive up or ... health services, according to a study performed by ... colleagues at other institutions. , The study in ... Genetics in Medicine was done by ...
(Date:5/17/2012)... have shown that zebrafish could be used to ... The study, published online in the journal ... their behaviour in response to varying situations. , ... Biological and Chemical Sciences who led the study, ... useful animal models for studying the developmental genetic ...
Breaking Biology News(10 mins):UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 2UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure 3NIH-led study finds genetic test results do not trigger increased use of health services 2NIH-led study finds genetic test results do not trigger increased use of health services 3NIH-led study finds genetic test results do not trigger increased use of health services 4Zebrafish could hold the key to understanding psychiatric disorders 2GEN point of view article questions reported costs of drug R 26amp 3BD 20192 1GEN point of view article questions reported costs of drug R 26amp 3BD 20192 2Microalgae could be Texas next big cash crop 20189 1Microalgae could be Texas next big cash crop 20189 2Microalgae could be Texas next big cash crop 20189 3Binge Eating May Be a High All Its Own 83454 1Binge Eating May Be a High All Its Own 83454 2Binge Eating May Be a High All Its Own 83454 3(Date:5/16/2012)... May 16, 2012 Questcor Pharmaceuticals, Inc. (NASDAQ: ... Board of Directors has increased the Company,s common ... million shares. Since the beginning of ... shareholders through the repurchase of approximately 19.2 million ... its shares as of the commencement of the ...
(Date:5/15/2012)... Researchers have taken a step toward overcoming ... structures that could bring optical advances including ... The researchers have shown how to create ... gold previously required, said Alexandra Boltasseva, a ... computer engineering. , Using the metals is ...
(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...
(Date:5/14/2012)... connection, if any, between sudden cardiac death and people ... lives? , In a comprehensive, 10-year UCSF study, researchers ... a rate four times higher than the general population. ... we were looking at every instance of sudden death ... MD, an electrophysiologist and an associate professor of medicine ...
Breaking Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11Are people with HIV/AIDS more prone to sudden cardiac death? 2Are people with HIV/AIDS more prone to sudden cardiac death? 3... HALIFAX, May 28 /PRNewswire-FirstCall/ - MedMira Inc., ("MedMira") (TSX ... and marketer of rapid diagnostic technology and solutions, announced ... Company,s U.S. distribution network. Headquartered in West Chester, Pennsylvania, ... with worldwide sales in excess of $3.7 billion. , ...
... The Food and Drug Administration (FDA) has granted ... Prograf(R) (tacrolimus) in conjunction with mycophenolate mofetil (MMF) for ... Prograf is a cornerstone therapy for preventing transplant ... approval came on May 19, 2009 in response to ...
... of Global Distribution Agreements to Make ZyGEM,s Lower-Cost, ... Researchers Everywhere--ZyGEM Also Announces Issuance of U.S. Patent ... Calif. and HAMILTON, New Zealand and ANN ... today announced that it has entered into an ...
Other Biology Technology:MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States 2Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 2Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 3Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 4Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 5Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients 6ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 2ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 3ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products 4... system designed for flexibility and routine operation. ... ion lens, true hyperbolic quadrupole and high-speed ... widest range of sample types and applications. ... as standard Agilents unique ShieldTorch System, which ...
... except that it uses a deep-UV deuterium bulb, ... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light Source ... halogen light sources in a single optical path. ...
... OPTIMA is a fully automated microplate ... the widest possible range of applications ... gene assays luciferase, -galactosidase, gene activities ... dioxetanes..) Luminescent Immunoassays Cell-based ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
Biology Products:Biology NavigationMedical Navigation